Skip to main content
OpenTrials

Clinical trial condition

Mast Cell Activation Disorders

Explore clinical trials studying Mast Cell Activation Disorders. Study availability and eligibility vary by location and protocol.

96 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Mast Cell Activation Disorders trial results

Completed

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060

Conditions
Bone Diseases, Bone Diseases, Metabolic, Immune System Diseases, +12 more
Locations
  • Jean Minjoz Hospital, Dermatology department Besançon, France
  • Caen Hospital, Clinical haematology department Caen, France
  • Estaing Hospital, Cellular therapy and clinical haematology department Clermont-Ferrand, France
  • Lille CHRU Hospital, Internal medicine and clinical immunology department Lille, France
View Trial Details
Completed

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

NCT04761822

Conditions
Allergic Reaction, COVID-19, Coronaviridae Infections, +21 more
Locations
  • University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine Tucson, Arizona, United States
  • Arkansas Children's, University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Los Angeles Medical Center Los Angeles, California, United States
  • Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research Stanford, California, United States
View all 29 locations
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study of Mast Cell Precursors

NCT00001756

Conditions
Healthy Volunteer, Immune System Diseases, Mast Cell Activation Disorders, +6 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details

Related conditions